145 related articles for article (PubMed ID: 1989637)
41. Synergistic action of tiazofurin and genistein on growth inhibition and differentiation of K-562 human leukemic cells.
Li W; Weber G
Life Sci; 1998; 63(22):1975-81. PubMed ID: 9839541
[TBL] [Abstract][Full Text] [Related]
42. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.
Olah E; Natsumeda Y; Ikegami T; Kote Z; Horanyi M; Szelenyi J; Paulik E; Kremmer T; Hollan SR; Sugar J
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6533-7. PubMed ID: 2901100
[TBL] [Abstract][Full Text] [Related]
43. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
[TBL] [Abstract][Full Text] [Related]
44. Potent inhibitors of human inosine monophosphate dehydrogenase type II. Fluorine-substituted analogues of thiazole-4-carboxamide adenine dinucleotide.
Zatorski A; Goldstein BM; Colby TD; Jones JP; Pankiewicz KW
J Med Chem; 1995 Mar; 38(7):1098-105. PubMed ID: 7707313
[TBL] [Abstract][Full Text] [Related]
45. p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene.
Gharehbaghi K; Burgess GS; Collart FR; Litz-Jackson S; Huberman E; Jayaram HN; Boswell HS
Leukemia; 1994 Aug; 8(8):1257-63. PubMed ID: 7520100
[TBL] [Abstract][Full Text] [Related]
46. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
Szekeres T; Fritzer M; Pillwein K; Felzmann T; Chiba P
Life Sci; 1992; 51(16):1309-15. PubMed ID: 1357518
[TBL] [Abstract][Full Text] [Related]
47. Nicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by Tiazofurin.
Kusumanchi P; Zhang Y; Jani MB; Jayaram NH; Khan RA; Tang Y; Antony AC; Jayaram HN
Cancer Gene Ther; 2013 Jul; 20(7):403-12. PubMed ID: 23764899
[TBL] [Abstract][Full Text] [Related]
48. Carboxamide group conformation in the nicotinamide and thiazole-4-carboxamide rings: implications for enzyme binding.
Li H; Goldstein BM
J Med Chem; 1992 Sep; 35(19):3560-7. PubMed ID: 1357174
[TBL] [Abstract][Full Text] [Related]
49. Involvement of guanine nucleotides in superoxide release by fluoride-treated neutrophils. Implications for a role of a guanine nucleotide regulatory protein.
English D; Rizzo MT; Tricot G; Hoffman R
J Immunol; 1989 Sep; 143(5):1685-91. PubMed ID: 2547872
[TBL] [Abstract][Full Text] [Related]
50. Phase I evaluation and pharmacokinetics of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
Melink TJ; Von Hoff DD; Kuhn JG; Hersh MR; Sternson LA; Patton TF; Siegler R; Boldt DH; Clark GM
Cancer Res; 1985 Jun; 45(6):2859-65. PubMed ID: 3986813
[TBL] [Abstract][Full Text] [Related]
51. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
Sokoloski JA; Sartorelli AC
Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
[TBL] [Abstract][Full Text] [Related]
52. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
53. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part I. In vivo studies.
Malek K; Boosalis MS; Waraska K; Mitchell BS; Wright DG
Leuk Res; 2004 Nov; 28(11):1125-36. PubMed ID: 15380335
[TBL] [Abstract][Full Text] [Related]
54. The linkage of glucose to tiazofurin decreases in vitro uptake into rat glioma C6 cells.
Dacevic MP; Tasic JS; Pejanovic VM; Segal MB; Ugliesic-Kilibarda DD; Isakovic AJ; Begley DJ; Rakic LM; Redzic ZB
J Drug Target; 2002 Dec; 10(8):633-6. PubMed ID: 12683668
[TBL] [Abstract][Full Text] [Related]
55. Metabolism of tiazofurin by human erythrocytes and mononuclear blood cells in vitro.
Roberts JD; Tong WP; Hartshorn JN; Hacker MP
Cancer Lett; 1986 Aug; 32(2):193-7. PubMed ID: 3756845
[TBL] [Abstract][Full Text] [Related]
56. Tiazofurin decreases Ras-GTP complex in K562 cells.
Hata Y; Natsumeda Y; Weber G
Oncol Res; 1993; 5(4-5):161-4. PubMed ID: 8305741
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of thiazole-4-carboxamide adenine dinucleotide. A powerful inhibitor of IMP dehydrogenase.
Gebeyehu G; Marquez VE; Kelley JA; Cooney DA; Jayaram HN; Johns DG
J Med Chem; 1983 Jun; 26(6):922-5. PubMed ID: 6133956
[TBL] [Abstract][Full Text] [Related]
58. Regulation of de novo and salvage pathways in chemotherapy.
Weber G; Nagai M; Natsumeda Y; Ichikawa S; Nakamura H; Eble JN; Jayaram HN; Zhen WN; Paulik E; Hoffman R
Adv Enzyme Regul; 1991; 31():45-67. PubMed ID: 1877399
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
Harrison SD; O'Dwyer PJ; Trader MW
Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
[TBL] [Abstract][Full Text] [Related]
60. The disposition and metabolism of tiazofurin in rodents, rabbits, and dogs.
Arnold ST; Jayaram HN; Harper GR; Litterst CL; Malspeis L; DeSouza JJ; Staubus AE; Ahluwalia GS; Wilson YA; Cooney DA
Drug Metab Dispos; 1984; 12(2):165-73. PubMed ID: 6144481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
